Cargando…

Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates

The selective, high affinity A(2B) adenosine receptor (AdoR) antagonists that were synthesized by several research groups should aid in determining the role of the A(2B) AdoR in inflammatory diseases like asthma or rheumatoid arthritis (RA) and angiogenic diseases like diabetic retinopathy or cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalla, Rao V., Zablocki, Jeff
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721775/ https://www.ncbi.nlm.nih.gov/pubmed/18568423 http://dx.doi.org/10.1007/s11302-008-9119-x

Ejemplares similares

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes
por: Bolcato, Chiara, et al.
Publicado: (2007)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Discovery of a High Affinity Adenosine A(1)/A(3) Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold
por: Suchankova, Anna, et al.
Publicado: (2022)

Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors
por: Gessi, Stefania, et al.
Publicado: (2006)

Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
por: Prieto-Díaz, Rubén, et al.
Publicado: (2022)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A(2B) Receptor Binding Affinity
por: Lindemann, Marcel, et al.
Publicado: (2021)

Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression
por: López-Cruz, Laura, et al.
Publicado: (2018)

A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

Affinities or Apparent Affinities of the Transport Adenosine Triphosphatase System
por: Glynn, I. M., et al.
Publicado: (1969)

Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype
por: Chałupnik, Paulina, et al.
Publicado: (2022)

Crystal structure of adenosine A(2A) receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction
por: Claff, Tobias, et al.
Publicado: (2023)

Molecular Simulations and Drug Discovery of Adenosine Receptors
por: Wang, Jinan, et al.
Publicado: (2022)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Identification of V6.51L as a selectivity hotspot in stereoselective A(2B) adenosine receptor antagonist recognition
por: Wang, Xuesong, et al.
Publicado: (2021)

Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A(2B) Adenosine Receptors
por: Kim, Yong-Chul, et al.
Publicado: (1999)

Pharmacological characterisation of novel adenosine A(3) receptor antagonists
por: Barkan, Kerry, et al.
Publicado: (2020)

An Affinity-Based Probe for the Human Adenosine A(2A) Receptor
por: Yang, Xue, et al.
Publicado: (2018)

Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse
por: Carré, Nadège, et al.
Publicado: (2014)

Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy
por: Min, Hye Sook, et al.
Publicado: (2016)

Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptor
por: Gao, Zhan-Guo, et al.
Publicado: (2008)

Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A(1) Adenosine Receptor Antagonists
por: Kolb, Peter, et al.
Publicado: (2012)

Antiplatelet Effects of Selected Xanthine-Based Adenosine A(2A) and A(2B) Receptor Antagonists Determined in Rat Blood
por: Kubacka, Monika, et al.
Publicado: (2023)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

A covalent antagonist for the human adenosine A(2A) receptor
por: Yang, Xue, et al.
Publicado: (2016)

Tumor Immunotherapy Using A(2A) Adenosine Receptor Antagonists
por: Zhang, Jinfeng, et al.
Publicado: (2020)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
por: Preti, Barbara, et al.
Publicado: (2022)

Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy
por: Yu Koh, Xin, et al.
Publicado: (2022)

Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
por: Yang, Zijian, et al.
Publicado: (2015)

New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations
por: Bolcato, Giovanni, et al.
Publicado: (2020)

C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range
por: Janse van Rensburg, Helena D., et al.
Publicado: (2020)

Discovery, Optimization, and Characterization of Novel D(2) Dopamine Receptor Selective Antagonists
por: Xiao, Jingbo, et al.
Publicado: (2014)

Development of a Radiofluorinated Adenosine A(2B) Receptor Antagonist as Potential Ligand for PET Imaging
por: Lindemann, Marcel, et al.
Publicado: (2020)

Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A(2B) adenosine receptor antagonists
por: Vlachodimou, Anna, et al.
Publicado: (2022)

PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity
por: Noberini, Roberta, et al.
Publicado: (2011)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Automated affinity selection for rapid discovery of peptide binders
por: Zhang, Genwei, et al.
Publicado: (2021)

Functional selectivity of adenosine receptor ligands
por: Verzijl, Dennis, et al.
Publicado: (2011)

Identification of Novel Adenosine A(2A) Receptor Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9tkk0rof8apfh0vs2ijogf6ur2